Lasa Supergenerics Ltd Falls 3.53%: 2 Key Events Shaping the Week

Jan 10 2026 01:01 PM IST

Share Via

Lasa Supergenerics Ltd experienced a volatile week from 5 to 9 January 2026, closing down 3.53% at Rs.10.93 despite outperforming the Sensex’s 2.62% decline. The stock’s price action was marked by a sharp rally midweek hitting an upper circuit on 7 January, followed by a steep fall to the lower circuit on 9 January amid heavy selling pressure. These circuit hits underscore the intense swings in investor sentiment and trading activity for this micro-cap pharmaceutical stock during a broadly weak market backdrop.

Key Events This Week

5 Jan: Stock opens at Rs.10.92, down 3.62%

7 Jan: Hits upper circuit amid strong buying pressure

9 Jan: Hits lower circuit amid heavy selling pressure

9 Jan: Week closes at Rs.10.93, down 3.53%

Week Open

Rs.11.33

Week Close

Rs.10.93

-3.53%

Week High

Rs.12.10

vs Sensex

+1.01%

5 January: Weak Start Amid Broad Market Decline

Lasa Supergenerics began the week on a subdued note, closing at Rs.10.92, down 3.62% from the previous Friday’s close of Rs.11.33. This decline was sharper than the Sensex’s 0.18% fall to 37,730.95, reflecting early selling pressure on the stock. The volume was relatively high at 89,326 shares, indicating active trading despite the negative sentiment. The broader market weakness set a cautious tone for the stock’s performance in the days ahead.

6 January: Strong Rebound Despite Sensex Dip

The stock rebounded sharply on 6 January, gaining 5.59% to close at Rs.11.53, outperforming the Sensex which declined 0.19% to 37,657.70. This recovery was supported by moderate volume of 31,449 shares. The bounce suggested renewed buying interest, possibly driven by short-covering or speculative demand, as the stock moved back above Rs.11.50. The divergence from the broader market’s decline highlighted stock-specific factors at play.

7 January: Upper Circuit Triggered on Robust Buying

Lasa Supergenerics surged to Rs.12.10 on 7 January, marking a 4.94% gain and hitting the upper circuit limit amid strong buying pressure. The stock closed near the day’s high, signalling intense demand that overwhelmed available supply. This move significantly outperformed the Sensex’s marginal 0.03% gain to 37,669.63 and the Pharmaceuticals & Biotechnology sector’s 0.64% rise. Despite the rally, delivery volumes declined, suggesting speculative trading rather than broad accumulation. The regulatory freeze capped further gains, leaving unfilled demand that could influence subsequent sessions.

8 January: Sharp Decline on Low Volume

The momentum reversed on 8 January as the stock fell 4.96% to Rs.11.50, underperforming the Sensex’s 1.41% drop to 37,137.33. The volume shrank sharply to 8,306 shares, indicating reduced investor participation. The decline followed the previous day’s upper circuit event, suggesting profit-taking or a correction after the strong rally. Delivery volumes also dropped significantly, pointing to a lack of sustained accumulation. The stock’s technical indicators showed short-term weakness despite medium-term support levels.

9 January: Lower Circuit Amid Heavy Selling Pressure

Lasa Supergenerics plunged to Rs.10.93 on 9 January, down 4.96%, hitting the lower circuit limit as intense selling overwhelmed buyers. This decline was sharper than the Sensex’s 0.89% fall to 36,807.62 and the sector’s 0.67% drop, highlighting stock-specific weakness. The total traded volume was moderate at 7,180 shares, but delivery volumes fell drastically, signalling panic selling and reduced long-term investor interest. The circuit breaker halted further losses, but the sharp fall underscored heightened volatility and bearish sentiment.

Daily Price Comparison: Lasa Supergenerics Ltd vs Sensex

Date	Stock Price	Day Change	Sensex	Day Change
2026-01-05	Rs.10.92	-3.62%	37,730.95	-0.18%
2026-01-06	Rs.11.53	+5.59%	37,657.70	-0.19%
2026-01-07	Rs.12.10	+4.94%	37,669.63	+0.03%
2026-01-08	Rs.11.50	-4.96%	37,137.33	-1.41%
2026-01-09	Rs.10.93	-4.96%	36,807.62	-0.89%

Key Takeaways

Positive Signals: The stock demonstrated resilience by outperforming the Sensex’s weekly decline of 2.62%, with a smaller 3.53% loss. The upper circuit hit on 7 January reflected strong buying interest and short-term bullish momentum. The stock remained above its 20-day, 50-day, and 100-day moving averages, indicating some medium-term technical support.

Cautionary Signals: The lower circuit hit on 9 January amid heavy selling pressure highlights significant volatility and investor uncertainty. Declining delivery volumes throughout the week suggest reduced long-term investor participation and possible speculative trading. The Mojo Score of 9.0 and Strong Sell rating underline fundamental concerns and micro-cap risks. The stock’s liquidity constraints and regulatory price band limits add to trading challenges.

Conclusion

Lasa Supergenerics Ltd’s week was defined by sharp swings between upper and lower circuit limits, reflecting a highly volatile trading environment amid a broadly weak market. While the stock showed moments of strong buying interest and outperformance relative to the Sensex, the heavy selling and circuit breaker on the final day signal caution. The micro-cap pharmaceutical stock’s fundamental rating remains negative, and investors should carefully weigh the technical momentum against underlying risks. Monitoring volume trends, delivery participation, and sector developments will be crucial in assessing the stock’s near-term trajectory.

Unlock special upgrade rates for a limited period. Start Saving Now →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE